Epogen/procrit and Abdominal obesity - from FDA reports


There is no Abdominal obesity reported by people who take Epogen/procrit yet. This review analyzes which people have Abdominal obesity with Epogen/procrit. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Epogen/procrit and have Abdominal obesity, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 13, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Abdominal obesity when taking Epogen/procrit?

Expand the study to include all drugs with the same ingredients

Abdominal obesity and drugs with ingredients of epoetin alfa.

Expand the study to include reports from both FDA and eHealthMe

Abdominal obesity and Epogen/procrit from FDA and eHealthMe reports


Epogen/procrit has active ingredients of epoetin alfa. It is often used in anemia. (latest outcomes from Epogen/procrit 80 users)

Abdominal Obesity

Abdominal obesity has been reported by people with asthma, depression, traumatic injury of the bladder and urethra, stable angina, rheumatoid arthritis (latest reports from 14 Abdominal obesity patients).

Browse all side effects of Epogen/procrit

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Abdominal obesity

Abdominal obesity

Could your condition cause Abdominal obesity

Abdominal obesity

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Epogen/procrit and have Abdominal obesity.

Questions to the study

More questions >

User reviews to the study

More reviews >